IKAP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Aurinia Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 13.89 EUR 4.59%

Market Cap: €6.9B

A	Aurinia Pharmaceuticals Inc SWB:IKAP	CA
	R E A Holdings PLC F:BY0	UK
K	Korian SA XBER:KO2	FR
K	Korian SA LSE:0OPS	FR

Profitability Summary

Aurinia Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

90%

Strong 3Y Average Gross Margin

90%

Declining Gross Margin

96% > 90%

Exceptional Operating Margin

42%

Negative 3Y Average Operating Margin

-6%

Operating Margin is Increasing

-52% > 42%

Exceptional Net Margin

100%

Low 3Y Average Net Margin

Net Margin is Increasing

-45% > 100%

Exceptional Free Cash Flow Margin

56%

Strong 3Y Average Free Cash Flow Margin

13%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.